 Quest Diagnostics Inc. DGX, 0.50 said Thursday its fourth-quarter net income fell to 390 million or 3.12 a share, from 579 million or 4.21 a share in the year-ago quarter. The blood testing companys adjusted net income dropped to 3.33 a share from 4.48 a share. 